Literature DB >> 8202551

Macromolecular permeability across the blood-nerve and blood-brain barriers.

J F Poduslo1, G L Curran, C T Berg.   

Abstract

The permeability of insulin (Ins), nerve growth factor (NGF), albumin (Alb), transferrin (Trf), and IgG across the blood-nerve barrier (BNB) and blood-brain barrier (BBB) in normal adult rats was quantified by measuring the (permeability coefficient x surface area) product (PS) with the i.v. bolus-injection technique in the cannulated brachial vein and artery using radioiodinated proteins. The PS values of the BNB for IgG and Alb were low: 0.079 +/- 0.029 x 10(-6) and 0.101 +/- 0.088 x 10(-6) ml.g-1.s-1, (mean +/- SD, respectively). The PS values for NGF and Trf were 16.1-fold and 25.5-fold higher than for Alb. The PS for Ins across the BNB was 33.190 +/- 2.053 x 10(-6) ml.g-1.s-1--a remarkable 329-fold increase compared with Alb. The PS values of the BBB for IgG and Alb in different brain regions were all low, from 0.028 +/- 0.017 to 0.151 +/- 0.035 x 10(-6) ml.g-1.s-1 (mean +/- SD). NGF and Trf had comparable PS values from 13- to 32-fold higher than for Alb, except for the brain stem, where the PS for Trf was 66-fold higher than for Alb. The mean PS for Ins across the BBB ranged from 15.78 +/- 5.45 x 10(-6) ml.g-1.s-1 for the cortex to 22.62 +/- 7.50 x 10(-6) ml.g-1.s-1 for the brain stem--again a remarkable 105- to 390-fold increase relative to Alb. Because reliable PS measurements were obtained for all proteins tested, the BBB and BNB cannot be considered impermeable to proteins--a concept that has plagued brain- and nerve-barrier research. The low PS values for IgG and Alb indicate low rates of transfer; however, Alb, in particular, is the major protein of endoneurial and ventricular fluid, which suggests that these PS values may be significant. Ins had the highest PS values, which likely reflect the mechanism of transport across the barriers--that is, receptor-mediated transport. Because NGF and Trf had PS values 13- to 66-fold higher than for Alb, whether this reflects receptor-mediated uptake, adsorptive-mediated transcytosis, or some other mechanism is unclear. That the PS values for NGF and Trf differ from Alb and IgG clearly suggests, however, a different uptake mechanism. Finally, the remarkably high PS values for Ins across the BBB and BNB identify this protein and its putative receptor on capillary endothelial cells as a potential target for drug delivery into the central and peripheral nervous systems.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8202551      PMCID: PMC44065          DOI: 10.1073/pnas.91.12.5705

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  81 in total

1.  Demonstration and structural comparison of receptors for insulin-like growth factor-I and -II (IGF-I and -II) in brain and blood-brain barrier.

Authors:  R G Rosenfeld; H Pham; B T Keller; R T Borchardt; W M Pardridge
Journal:  Biochem Biophys Res Commun       Date:  1987-11-30       Impact factor: 3.575

2.  Receptor-mediated transcytosis of transferrin across the blood-brain barrier.

Authors:  J B Fishman; J B Rubin; J V Handrahan; J R Connor; R E Fine
Journal:  J Neurosci Res       Date:  1987       Impact factor: 4.164

3.  Studies of albumin binding to rat liver plasma membranes. Implications for the albumin receptor hypothesis.

Authors:  W Stremmel; B J Potter; P D Berk
Journal:  Biochim Biophys Acta       Date:  1983-03-15

4.  Endocytosis of formaldehyde-denatured serum albumin by nonparenchymal liver cells in vitro.

Authors:  W Eskild; T Berg
Journal:  Biochim Biophys Acta       Date:  1984-02-17

5.  Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data.

Authors:  C S Patlak; R G Blasberg; J D Fenstermacher
Journal:  J Cereb Blood Flow Metab       Date:  1983-03       Impact factor: 6.200

6.  Altered blood-nerve barrier in experimental lead neuropathy assessed by changes in endoneurial albumin concentration.

Authors:  J F Poduslo; P A Low; A J Windebank; P J Dyck; C T Berg; J D Schmelzer
Journal:  J Neurosci       Date:  1982-10       Impact factor: 6.167

Review 7.  Methods for Quantifying the transport of drugs across brain barrier systems.

Authors:  J D Fenstermacher; R G Blasberg; C S Patlak
Journal:  Pharmacol Ther       Date:  1981       Impact factor: 12.310

8.  Blood-brain barrier transcytosis of insulin in developing rabbits.

Authors:  K R Duffy; W M Pardridge
Journal:  Brain Res       Date:  1987-09-08       Impact factor: 3.252

9.  Transcytosis of albumin in capillary endothelium.

Authors:  A J Milici; N E Watrous; H Stukenbrok; G E Palade
Journal:  J Cell Biol       Date:  1987-12       Impact factor: 10.539

10.  Differentiated microdomains on the luminal surface of the capillary endothelium. I. Preferential distribution of anionic sites.

Authors:  N Simionescu; M Simionescu; G E Palade
Journal:  J Cell Biol       Date:  1981-09       Impact factor: 10.539

View more
  104 in total

1.  Pargyline conjugate-induced long-term activation of monoamine oxidase as an immunological model for depression.

Authors:  R A Danilova; T A Moskvityna; M F Obukhova; M V Belopolskaya; I P Ashmarin
Journal:  Neurochem Res       Date:  1999-09       Impact factor: 3.996

2.  The effects of immunization against cholecystokinin fragment 30-33 in the behavior of white rats.

Authors:  R A Danilova; O I Rud'ko; T M Korotkova; M F Obukhova; I P Ashmarin
Journal:  Neurosci Behav Physiol       Date:  2002 Mar-Apr

3.  Deltorphin transport across the blood-brain barrier.

Authors:  A Fiori; P Cardelli; L Negri; M R Savi; R Strom; V Erspamer
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

Review 4.  Potential importance of B cells in aging and aging-associated neurodegenerative diseases.

Authors:  Arya Biragyn; Maria Aliseychik; Evgeny Rogaev
Journal:  Semin Immunopathol       Date:  2017-01-12       Impact factor: 9.623

5.  Pericyte-derived glial cell line-derived neurotrophic factor increase the expression of claudin-5 in the blood-brain barrier and the blood-nerve barrier.

Authors:  Fumitaka Shimizu; Yasuteru Sano; Kazuyuki Saito; Masa-aki Abe; Toshihiko Maeda; Hiroyo Haruki; Takashi Kanda
Journal:  Neurochem Res       Date:  2011-10-16       Impact factor: 3.996

6.  Cdc42 GTPases facilitate TNF-α-mediated secretion of CCL2 from peripheral nerve microvascular endoneurial endothelial cells.

Authors:  Kelly A Langert; Cynthia L Von Zee; Evan B Stubbs
Journal:  J Peripher Nerv Syst       Date:  2013-09       Impact factor: 3.494

Review 7.  Transporter pharmacogenetics: transporter polymorphisms affect normal physiology, diseases, and pharmacotherapy.

Authors:  Tristan M Sissung; Sarah M Troutman; Tessa J Campbell; Heather M Pressler; Hyeyoung Sung; Susan E Bates; William D Figg
Journal:  Discov Med       Date:  2012-01       Impact factor: 2.970

8.  Carbon nanotube inhibits the formation of β-sheet-rich oligomers of the Alzheimer's amyloid-β(16-22) peptide.

Authors:  Huiyu Li; Yin Luo; Philippe Derreumaux; Guanghong Wei
Journal:  Biophys J       Date:  2011-11-01       Impact factor: 4.033

9.  In Vitro and In Vivo Correlation of Bone Morphogenetic Protein-2 Release Profiles from Complex Delivery Vehicles.

Authors:  Maurits G L Olthof; Marianna A Tryfonidou; Mahrokh Dadsetan; Wouter J A Dhert; Michael J Yaszemski; Diederik H R Kempen; Lichun Lu
Journal:  Tissue Eng Part C Methods       Date:  2018-07       Impact factor: 3.056

10.  Surface plasmon resonance binding kinetics of Alzheimer's disease amyloid beta peptide-capturing and plaque-binding monoclonal antibodies.

Authors:  Muthu Ramakrishnan; Karunya K Kandimalla; Thomas M Wengenack; Kyle G Howell; Joseph F Poduslo
Journal:  Biochemistry       Date:  2009-11-03       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.